CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-03 | Turitz Andrew SVP - Business Development | Option exercise · Employee Stock Option (right to buy) | −1,390 | 8,334 | ||
| 2020-09-02 | Turitz Andrew SVP - Business Development | Option exercise | +717 | $38.55 | $28K | 4,732 |
| 2020-09-02 | Turitz Andrew SVP - Business Development | Sale | −717 | $227.80 | $163K | 4,015 |
| 2020-09-02 | Turitz Andrew SVP - Business Development | Option exercise · Employee Stock Option (right to buy) | −717 | 12,900 | ||
| 2020-09-01 | GOREVIC JASON N Chief Executive Officer | Option exercise | +30,000 | $6.01 | $180K | 697,283 |
| 2020-09-01 | GOREVIC JASON N Chief Executive Officer | Sale | −30,000 | $221.89 | $6.7M | 667,283 |
| 2020-09-01 | GOREVIC JASON N Chief Executive Officer | Option exercise · Employee Stock Option (right to buy) | −30,000 | 30,310 | ||
| 2020-09-01 | Verstraete Stephany Chief Marketing Officer | Option exercise | +6,000 | $22.30 | $134K | 19,276 |
| 2020-09-01 | Verstraete Stephany Chief Marketing Officer | Sale | −6,000 | $219.34 | $1.3M | 13,276 |
| 2020-09-01 | Verstraete Stephany Chief Marketing Officer | Option exercise · Employee Stock Option (right to buy) | −6,000 | 44,600 | ||
| 2020-09-01 | Levy Lewis Chief Medical Officer | Option exercise | +1,395 | $35.45 | $49K | 10,161 |
| 2020-09-01 | Levy Lewis Chief Medical Officer | Option exercise | +1,275 | $38.55 | $49K | 11,436 |
| 2020-09-01 | Levy Lewis Chief Medical Officer | Sale | −2,670 | $219.34 | $586K | 8,766 |
| 2020-09-01 | Levy Lewis Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −1,395 | 14,858 | ||
| 2020-09-01 | Levy Lewis Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −1,275 | 22,714 | ||
| 2020-09-01 | Bucaria Michelle Chief Human Resources Officer | Option exercise | +764 | $37.75 | $29K | 3,232 |
| 2020-09-01 | Bucaria Michelle Chief Human Resources Officer | Option exercise · Employee Stock Option (right to buy) | −764 | 25,498 | ||
| 2020-08-28 | Frist William H. Director | Option exercise | +740 | $6.01 | $4K | 6,158 |
| 2020-08-28 | Frist William H. Director | Sale | −740 | $217.50 | $161K | 5,418 |
| 2020-08-28 | Frist William H. Director | Option exercise · Stock Option (right to buy) | −740 | 58,310 |
Page 90 of 93 · 1,848 trades